|Title: ||Association of Tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers|
|Issue Date: ||12-Apr-2012|
|Description: ||RIGHTS : This article is licensed under the BioMed Central licence at http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'. In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.|
|Other Identifiers: ||http://dx.doi.org/10.1186/1897-4287-10-S2-A11|
|Appears in Collections:||Scholarly works - Public Health and Primary Care|
This item has been accessed 231 times.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.